Lactulose efficacy in reduction of nitrogen products, blood potassium and fluid overload in patients with end-stage renal failure
Journal Title: Journal of Pharmaceutical & Health Sciences - Year 2017, Vol 5, Issue 2
Abstract
Introduction. Chronic kidney disease (CKD) is a major public health problem that often goes unrecognized until late-stage disease. Patients with chronic kidney disease (CKD) face with uremic toxins and hyperkalemia. Also fluid overload in CKD patients is associated with rapid decline in kidney function. Lactulose is a hyper osmotic agent and as a prebiotic could reduce serum urea and potassium levels and have some effects on fluid overload. The aim of this study was to evaluate effect of lactulose on serum levels of biochemical products in patients with CKD. Materials and Methods. In this prospective before-after intervention study 17 patients with end stage of CKD ( 76.47 % men; mean age 65.88 ± 13.4) were evaluated. All patients received lactulose, 10 ml, 3 times per day for 3 months. Blood samples from all participants were collected before and at the end of intervention to examine changes in biochemical parameters, including potassium, urea, creatinine and uric acid. A P value less than 0.05 was considered significant. Results. Lactulose significantly decreased urea levels (p=0.001), blood potassium (0.001) and fluid overload (with due attention to patient’s weight p=0.001) in patients with end-stage renal failure. The decrease in serum creatinin and uric acid were not significant. Conclusions. Lactulose administration in CKD patients could decrease levels of various deleterious elements especially urea and blood potassium, The daily use of lactulose in CKD patients e suggested in order to receive better therapeutic results.
Authors and Affiliations
Negin Aleagha, Farahnaz Pasha, Maryam Shiehmorteza
Keywords
Related Articles
- EP ID EP214506
- DOI -
- Views 187
- Downloads 0
Analog kefir production with a low phenylalanine for Phenylketonuria
Phenylketonuria (PKU) is one of the most prevalent types of hereditary metabolic disorders which is caused due to an absence or reduction of the activity of the Phenylalanine hydroxylase enzyme in the liver which in turn...
Pharmacognostic Study of Argyreia pilosa Wight & Arn. Root
Background: Ethnomedicinally, the plant Argyreia pilosa Wight & Arn. (Convolvulaceae) has long been utilized in various disorders in the conventional system; most significantly it is utilized against sexually transmitted...
Major phytosteroid from Polygonatum orientale Desf. Rhizome
Polygonatum orientale Desf. (Asparagaceae) is herbaceous and perennial plant grown in northern parts of Iran. The rhizomes of Polygonatum, known as Iranian Shaghagho, is used in Iranian traditional medicine as tonic, aph...
Preparation of ZnO and ZnS nanoparticles and in-vitro study of their antimicrobial effect
Zinc sulfide (ZnS) & zinc oxide (ZnO) nanoparticles was evaluated for their antimicrobial activity against four pathogenic strains. ZnS&ZnO nanoparticles were synthesized by simple aqueous chemical reaction in an aqueous...
Nutritive Value and Mineral Elements of Wild Astragalus meridioalis sensu auct. Seeds in South of Iran
Literature survey revealed that there was no biological investigation on Astragalus meridioalis sensu auct. seeds worldwide. The mature seeds of A. meridioalis was collected in August 2015 from...